Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEART-FID: Ferric Carboxymaltose in Heart Failure with Iron Deficiency
NCT03037931Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- Mar 2017
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by American Regent, Inc.. Started Mar 2017; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03037931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03037931.